NextCure, Inc. (NXTC) Financials

NXTC Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 22.6 million 10.5 million
March 31, 2026 38.0 million 11.3 million
Dec. 31, 2025 50.2 million 15.2 million
Sept. 30, 2025 39.6 million 16.0 million

NXTC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.7 million 304000
March 31, 2026 -13.4 million 344000
Dec. 31, 2025 -7.6 million 435000
Sept. 30, 2025 -6.3 million 600000

NXTC Net Income

No data available :(

NXTC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 20.1 million - 3.6 million
March 31, 2026 29.7 million 3.9 million 3.9 million
Dec. 31, 2025 41.8 million - 5.2 million
Sept. 30, 2025 29.1 million 4.4 million 4.4 million

NXTC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 5.3 million
March 31, 2026 5.2 million
Dec. 31, 2025 3.5 million
Sept. 30, 2025 2.7 million

NXTC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 7.4 million 2.6 million -
March 31, 2026 - 6.8 million 3.3 million -
Dec. 31, 2025 - 6.8 million 3.0 million -
Sept. 30, 2025 - 6.1 million 2.8 million -

NXTC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 283000
Dec. 31, 2025 - 365000
Sept. 30, 2025 - -

NXTC

Price: $6.78

52 week price:
1.55
15.74

Earnings Per Share: -10.03 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 224200

Market Capitalization: 37.4 million

Links: